MedTrace Logo

A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms

NCT03642639 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 723

Last updated 2026-05-14

No results posted yet for this study

Summary

A post-market registry evaluating ruptured/unruptured aneurysms treated with MICRUSFRAME and GALAXY coils

Conditions

  • Aneurysms

Interventions

DEVICE

MICRUSFRAME and GALAXY coils

MICRUSFRAME and GALAXY Coils

Sponsors & Collaborators

  • Cerenovus, Part of DePuy Synthes Products, Inc.

    lead INDUSTRY

Principal Investigators

  • Reade De Leacy · Mount Sinai Hospital, New York

  • Osama Zaidat · Mercy Health St. Vincent Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-23
Primary Completion
2025-06-12
Completion
2025-06-12
FDA Device
Yes

Countries

  • United States
  • Belgium
  • France
  • Germany
  • Israel
  • Italy
  • Japan
  • Portugal
  • Spain
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03642639 on ClinicalTrials.gov